• Tuesday, Nov 24, 2020
  • Last Update : 09:23 am

Covid-19 vaccine: The next steps

  • Published at 01:19 pm November 21st, 2020
Pfizer Covid-19 Vaccine
File photo: Vials with a sticker reading, ‘Covid-19 / Coronavirus vaccine / Injection only’ and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken on October 31, 2020 Reuters

The FDA could provide emergency authorization as soon as the first two weeks of December

With US pharmaceutical giant Pfizer and its German partner BioNTech applying for an emergency use authorization in the United States for their coronavirus vaccine and US biotech company Moderna expected to do so soon, here are the next steps in the approval and distribution process:

Evaluation begins right away 

The US Food and Drug Administration (FDA) will immediately begin evaluating the results of the Covid-19 vaccine clinical trials conducted by Pfizer/BioNTech.

They will concentrate on the safety of the vaccine and its effectiveness, which has been billed at 95% by Pfizer/BioNTech.

FDA commissioner Stephen Hahn said the approval process will include a public meeting of the FDA's vaccine advisory committee, which includes experts in infectious diseases, pediatrics, biostatistics and industry representatives.

The committee's recommendations are not binding, however, and a final decision on whether or not to authorize the vaccine will be up to the scientists at the FDA.

Green light: December 

The FDA could provide emergency authorization as soon as the first two weeks of December, according to Moncef Slaoui, the chief scientist for "Operation Warp Speed," the US government initiative to develop a Covid-19 vaccine.

It would be a conditional approval in the context of the global health crisis and would restrict distribution of the vaccine to certain members of the population.

Children, for example, would not be included because Pfizer has not yet conducted widespread testing of the vaccine among those under the age of 18.

Another US government agency, the Centers for Disease Control and Prevention (CDC), would determine the order of priority for distribution of the vaccine.

Front-line medical workers and elderly residents of nursing homes would probably be among the first to be inoculated.

In Europe, Britain, Canada, Japan and Australia, the process is slightly different and regulators there have been constantly reviewing the data from clinical trials being conducted by several manufacturers.

The European Union could give a green light to a vaccine as early as the second half of December, according to European Commission president Ursula von der Leyen.

Distribution: late December  

Pfizer/BioNTech said doses of the vaccine would be ready for distribution "within hours" after US authorization, which could mean shipments beginning in the second half of December.

They would initially be provided by a US factory in Kalamazoo, Michigan, and a Belgian plant in Puurs.

The vaccine must be stored at -70°C temperatures much colder than those of a standard freezer.

Pfizer would distribute the doses to vaccination centers in containers filled with dry ice which should keep the vaccine at the required temperature for 15 days.

Next vaccines: early 2021       

The Moderna Covid-19 vaccine could be ready for distribution soon after that of Pfizer/BioNTech and could be followed by February by that of Johnson & Johnson, according to Slaoui, with AstraZeneca/Oxford also expected in the next few months.

While high-risk groups will be the first vaccinated, the US government hopes that there will be enough vaccines by April 2021 to offer it to the broader population and provide high coverage by the summer.


55
54
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail